1919 Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

1919 Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$7.12M	Buy	139,092 +330	+0.2%	+$16.5K	0.15%	145
2014 Q2	$6.73M	Buy	138,762 +1,847	+1%	+$91K	0.14%	142
2014 Q1	$7.11M	Sell	136,915 -5,641	-4%	-$300K	0.15%	134
2013 Q4	$7.58M	Buy	142,556 +650	+0.5%	+$33.1K	0.16%	128
2013 Q3	$6.57M	Sell	141,906 -306	-0.2%	-$13.4K	0.15%	133
2013 Q2	$6.36M	Buy	+142,212	New	+$6.17M	0.15%	129

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

1919 Investment Counsel's BMY Position: Q3 2014 in Review

1919 Investment Counsel increased its Bristol-Myers Squibb (BMY) stake by 0.24% in Q3 2014, buying an estimated $16.5K and bringing the position to 139,092 shares worth $7.12M. The position accounts for 0.15% of the portfolio, ranked #145.

1919 Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.58M in Q4 2013. 1,303 funds tracked by Wall St. Rank hold BMY as of Q3 2014.

1919 Investment Counsel held 139,092 shares of Bristol-Myers Squibb worth $7.12M as of Q3 2014.
1919 Investment Counsel bought 330 Bristol-Myers Squibb shares in Q3 2014, an estimated $16.5K.
Bristol-Myers Squibb made up 0.15% of 1919 Investment Counsel's portfolio in Q3 2014, its #145 holding.
1919 Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 6 quarters since.
1919 Investment Counsel's Bristol-Myers Squibb position peaked at $7.58M in Q4 2013.
1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.